Clinical Trials Logo
  1. Home
  2. AIDS/HIV PROBLEM
  3. NCT02219672

Study on the Impact of Triptolide Woldifiion on HIV-1 Reservoir In Acute HIV-1 Infection

AIDS/HIV PROBLEM Clinical Trial

Official title:
Study on the Impact of Triptolide Woldifiion on HIV-1 Reservoir of Chinese HIV/AIDS Patients In Acute HIV-1 Infection

Clinical Trial Summary

This study is a prospective trial which will recruit 18 patients in acute HIV-1 infection phase. This study aims to evaluate the effects and side effects of ARV treatment in Chinese patients in acute HIV-1 infection phase, and to evaluate the impact of Triptolide wilfordii on HIV-1 reservoir.

Clinical Trial Description

Two arms will be enrolled in this study, 18 naive-treatment Chinese patients in acute HIV-1 infection phase would be allocated to two arms, and treated with the antiretroviral drugs (Tenofovir plus lamivudine plus Lopinavir / ritonavir plus raltegravir). Six months later, 12 patients will be treated with Triplitode, in order to observe the impact of of Triptolide wilfordii on HIV-1 reservoir of patients in acute infection phase. All patients should be explored for 18 months in terms of the clinical features, drugs side-effects, and immunological and viral response, and the HIV-1 reservoir. We hypothesis that Triptolide wilfordii might further reduce the HIV-1 reservoir. The result would provide proofs for further practical antiviral therapy for patients in acute infection phase in China or other resource limited countries. ;

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Factorial Assignment, Masking: Open Label, Primary Purpose: Prevention

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT02219672
Study type Interventional
Source Peking Union Medical College
Contact Wei Lv, MD
Phone 8610-69155046
Email lvweipumch@163.com
Status Recruiting
Phase Phase 3
Start date July 2014
Completion date July 2017
View Details
See also
  Status Clinical Trial Phase
Completed NCT04653441 - Resilience-based Psychosocial Intervention Among Children Affected by HIV/AIDS N/A
Completed NCT01507142 - Rapid Oral Test for Therapeutic Response in HIV/AIDS Patients N/A
Not yet recruiting NCT01844310 - Raltegravir-based Antiretroviral Therapy for Resistant HIV-1 Infection N/A
Not yet recruiting NCT01844297 - Efficacy and Safety of Tenofovir Plus Lamivudine Plus Efavirenz Regimen as First-line Antiretroviral Therapy N/A
Completed NCT05065905 - Study of Interferon-Gamma in the Complex Treatment of Patients Infected With HIV and Tuberculosis Phase 1/Phase 2
Withdrawn NCT04144335 - N-803 Combined With the Broadly Neutralizing Antibodies Plus or Minus haNK Cells for HIV Phase 1/Phase 2
Active, not recruiting NCT01589965 - The Impact of Short-term Financial Incentives on Sexual Behavior and HIV Incidence in Lesotho Phase 0